320 related articles for article (PubMed ID: 26159281)
21. Impact of therapy on the long-term outcome of chronic hepatitis B.
Liaw YF
Clin Liver Dis; 2013 Aug; 17(3):413-23. PubMed ID: 23905813
[TBL] [Abstract][Full Text] [Related]
22. [Therapy of hepatitis B virus infection].
Trautwein C
Praxis (Bern 1994); 2006 Sep; 95(36):1389-97. PubMed ID: 16989182
[TBL] [Abstract][Full Text] [Related]
23. Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.
Shin HS; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Baatarkhuu O; Ahn SH
J Gastroenterol Hepatol; 2012 Sep; 27(9):1528-34. PubMed ID: 22497450
[TBL] [Abstract][Full Text] [Related]
24. Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy.
Arora G; Keeffe EB
Rev Gastroenterol Disord; 2007; 7(2):63-73. PubMed ID: 17597674
[TBL] [Abstract][Full Text] [Related]
25. Chronic Hepatitis B Infection: A Review.
Tang LSY; Covert E; Wilson E; Kottilil S
JAMA; 2018 May; 319(17):1802-1813. PubMed ID: 29715359
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
[TBL] [Abstract][Full Text] [Related]
27. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability.
Kim GA; Lim YS; An J; Lee D; Shim JH; Kim KM; Lee HC; Chung YH; Lee YS; Suh DJ
Gut; 2014 Aug; 63(8):1325-32. PubMed ID: 24162593
[TBL] [Abstract][Full Text] [Related]
28. Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B.
Kim HS; Kim BK; Kim SU; Park JY; Kim DY; Song KJ; Park JW; Kim YJ; Baatarkhuu O; Han KH; Ahn SH
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1647-1656.e6. PubMed ID: 27305847
[TBL] [Abstract][Full Text] [Related]
29. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
[TBL] [Abstract][Full Text] [Related]
30. Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.
Qu J; Yu Z; Li Q; Chen Y; Xiang D; Tan L; Lei C; Bai W; Li H; Shang Q; Chen L; Hu X; Lu W; Li Z; Chen D; Wang X; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Chen G; Li Y; Zeng Z; Rong G; Dong Z; Chen Y; Lou M; Wang C; Lu Y; Zhang C; Yang Y
Trials; 2014 Nov; 15():438. PubMed ID: 25381721
[TBL] [Abstract][Full Text] [Related]
31. Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Kim WR; Loomba R; Berg T; Aguilar Schall RE; Yee LJ; Dinh PV; Flaherty JF; Martins EB; Therneau TM; Jacobson I; Fung S; Gurel S; Buti M; Marcellin P
Cancer; 2015 Oct; 121(20):3631-8. PubMed ID: 26177866
[TBL] [Abstract][Full Text] [Related]
32. Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?
Lampertico P; Viganò M; Colombo M
Liver Int; 2013 Feb; 33 Suppl 1():157-63. PubMed ID: 23286860
[TBL] [Abstract][Full Text] [Related]
33. Management of chronic hepatitis B in severe liver disease.
Fung J; Lai CL; Yuen MF
World J Gastroenterol; 2014 Nov; 20(43):16053-61. PubMed ID: 25473157
[TBL] [Abstract][Full Text] [Related]
34. Does chemotherapy prevent HBV-related hepatocellular carcinoma? Cons.
Colombo M
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S298-301. PubMed ID: 20547318
[TBL] [Abstract][Full Text] [Related]
35. Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.
Buster EH; Hansen BE; Buti M; Delwaide J; Niederau C; Michielsen PP; Flisiak R; Zondervan PE; Schalm SW; Janssen HL;
Hepatology; 2007 Aug; 46(2):388-94. PubMed ID: 17604363
[TBL] [Abstract][Full Text] [Related]
36. Does chemotherapy prevent HBV-related hepatocellular carcinoma? Pros.
Liaw YF
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S293-7. PubMed ID: 20547317
[TBL] [Abstract][Full Text] [Related]
37. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
Buster EH; Schalm SW; Janssen HL
Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
[TBL] [Abstract][Full Text] [Related]
38. Treatment of chronic hepatitis B: Evolution over two decades.
Yuen MF; Lai CL
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
[TBL] [Abstract][Full Text] [Related]
39. Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting.
Idilman R; Gunsar F; Koruk M; Keskin O; Meral CE; Gulsen M; Elhan AH; Akarca US; Yurdaydin C
J Viral Hepat; 2015 May; 22(5):504-10. PubMed ID: 25431108
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Nikolopoulou G; Raptopoulou-Gigi M; Gogos C; Vafiadis-Zouboulis I; Karamanolis D; Chouta A; Ilias A; Drakoulis C; Mimidis K; Ketikoglou I; Manesis E; Mela M; Hatzis G; Dalekos GN;
J Viral Hepat; 2015 Feb; 22(2):120-7. PubMed ID: 25040685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
